Evidence map›Paper›PMID 26911930›Full record

ArticleParasites & vectors2016

Unique PFK regulatory property from some mosquito vectors of disease, and from Drosophila melanogaster.

Rodrigo Dutra Nunes, Nelilma Correia Romeiro, Hugo Tremonte De Carvalho, Jean Ribeiro Moreira, Mauro Sola-Penna, Mário Alberto C Silva-Neto, Glória Regina Cardoso Braz

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Roles ofFrontiers in physiology · 2023
    Article
  2. Article
  3. Frontiers in oncology · 2022
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. ADisease models & mechanisms · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rodrigo Dutra NunesInstituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. rdnunes@bioqmed.ufrj.br.
Nelilma Correia RomeiroDepartamento de Química Orgânica, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. Nelilma@iq.ufrj.br.
Hugo Tremonte De CarvalhoDepartamento de Bioquímica, Instituto de Química, Universidade Federal do Rio de Janeiro, Riode Janeiro, RJ, Brazil. hugo.carvalho@ime.uerj.br.
Jean Ribeiro MoreiraDepartamento de Bioquímica, Instituto de Química, Universidade Federal do Rio de Janeiro, Riode Janeiro, RJ, Brazil. je.ri@hotmail.com.
Mauro Sola-PennaFaculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. maurosp@pharma.ufrj.br.
Mário Alberto C Silva-NetoInstituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. maneto@bioqmed.ufrj.br.
Glória Regina Cardoso BrazDepartamento de Bioquímica, Instituto de Química, Universidade Federal do Rio de Janeiro, Riode Janeiro, RJ, Brazil. gbraz@iq.ufrj.br.
Universidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundArthropod-borne diseases are some of the most rapidly spreading diseases. Reducing the vector population is currently the only effective way to reduce case numbers. Central metabolic pathways are potential targets to control vector populations, but have not been well explored to this aim. The information available on energy metabolism, as a way to control lifespan and dispersion through flight of dipteran vectors, is inadequate.

methodsPhosphofructokinase (PFK) activity was measured in the presence of both of its substrates, fructose-6-phosphate (F6P) and ATP, as well as some allosteric effectors: Fructose- 2,6 - bisphosphate (F2, 6BP), citrate and AMP. Aedes aegypti phosphofructokinase sequence (AaPFK) was aligned with many other insects and also vertebrate sequences. A 3D AaPFK model was produced and docking experiments were performed with AMP and citrate.

resultsThe kinetic parameters of AaPFK were determined for both substrates: F6P (V = 4.47 ± 0.15 μmol of F1, 6BP/min, K0.5 = 1.48 ± 0.22 mM) and ATP (V = 4.73 ± 0.57 μmol of F1, 6BP/min, K0.5 = 0.43 ± 0.10 mM). F2,6P was a powerful activator of AaPFK, even at low ATP concentrations. AaPFK inhibition by ATP was not enhanced by citrate, consistent with observations in other insects. After examining the sequence alignment of insect and non-insect PFKs, the hypothesis is that a modification of the citrate binding site is responsible for this unique behavior. AMP, a well-known positive effector of PFK, was not capable of reverting ATP inhibition. Aedes, Anopheles and Culex are dengue, malaria and filariasis vectors, respectively, and are shown to have this distinct characteristic in phosphofructokinase control. The alignment of several insect PFKs suggested a difference in the AMP binding site and a significant change in local charges, which introduces a highly negative charge in this part of the protein, making the binding of AMP unlikely. This hypothesis was supported by 3D modeling of PFK with AMP docking, which suggested that the AMP molecule binds in a reverse orientation due to the electrostatic environment. The present findings imply a potential new way to control PFK activity and are a unique feature of these Diptera.

conclusionsThe present findings provide the first molecular explanation for citrate insensitivity in insect PFKs, as well as demonstrating for the first time AMP insensitivity in dipterans. It also identified a potential target for novel insecticides for the control of arthropod-borne diseases.

Indexed as

Insect VectorsAdenosine MonophosphateAdenosine TriphosphateAnimalsCitratesCulicidaeDrosophila melanogasterFructosediphosphatesFructosephosphatesKineticsModels, MolecularMolecular Docking SimulationPhosphofructokinase-1Protein ConformationAdenosine MonophosphateAdenosine TriphosphateCitratesfructose 2,6-diphosphatefructose-6-phosphateFructosediphosphatesFructosephosphatesPhosphofructokinase-1

Identifiers

PMID26911930
PMCPMC4766633
OpenAlexW2282645572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.